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Background and purpose: The aim of this study was to compare results of clipping and coiling
for aneurysms of the anterior circle of Willis. Previous studies have not identiﬁed a clear
superiority of one method over the other.
Material and methods: The study group included 165 consecutive patients. The assessment
took into account the risk of death, neurological status according to the scale of the GOS and
mRS, the incidence of early complications and quality of life measured by own surveys and
questionnaire EORTC QLQ-C30 v. 3.0.
Results: Mean follow-up was more than four years. Early and late results of treatment after
embolization and clipping for all patients did not differ. Evaluation of patients with bleeding
aneurysms demonstrated better outcomes after embolization, however statistical signiﬁcance
was observed only in terms of symptomatic scale score of QLQ-C30 questionnaire ( p = 0.02). For
patients with non-bleeding aneurysms better outcomes were obtained after clipping, but
statistical signiﬁcance was found only in the early results: more excellent results in GOS score
at discharge ( p < 0.03) and fewer complications during hospitalization ( p = 0.02).
Conclusions: Results of treatment after clipping and coiling do not differ in total for all
patients, but differ depending on the presence of bleeding. Patients with bleeding aneurysms
achieve better outcomes after coiling, and patients with non-bleeding aneurysms achieve
better outcomes after clipping.
# 2014 Polish Neurological Society. Published by Elsevier Urban & Partner Sp. z o.o. All
rights reserved.
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Owing to the development of the vascular neurosurgery in the
middle of the 20th century clipping has become an unrivalled* Corresponding author at: Marcin Birski, Klinika Neurochirurgii, 10 W
Bydgoszcz, Poland. Tel.: +48 604255816; fax: +48 523787094.
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0028-3843/# 2014 Polish Neurological Society. Published by Elsevier Umethod of treating intracranial aneurysms [1]. The new
revolution has been brought about by the introduction of
the detachable coils in 1990 by Guido Guglielmi and the Boston
Scientiﬁc company brieﬂy called GDC (Guglielmi Detachable
Coils) [2]. In the following years there was a rapid developmentojskowy Szpital Kliniczny, ul. Powstańców Warszawy 5, 85-681
rban & Partner Sp. z o.o. All rights reserved.
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treatment of cerebral aneurysms supported by technical
progress with regard to the structure of the coils and the
methods of their application. The introduction of stents, ﬁrst
described by Higashida in 1997, has additionally broadened the
possibilities and the range of the indications as to the treatment
[3]. Coiling, initially treated as a complementary method applied
in cases of limited possibilities of surgical treatment, has not
only become competitive but in certain ﬁelds started to
substitute clipping. Contemporarily, in the majority of cases
the primary aim of treating aneurysms which is the protection
from bleeding may be obtained both by clipping and coiling. The
advantage of the embolization is a shorter time of the procedure,
a reduction of typical surgical complications such as infections
or bleeding and the unnecessity of the brain compression and its
aftermaths. The less permanent effect of treatment and,
consequently, more frequent necessity of repeating interven-
tion are considered to be the biggest disadvantages of coiling
[4,5]. Moreover, more frequently aneurysms initially planned for
endovascular treatment are eventually clipped than the other
way round [6,7]. In case of certain complications after
embolization, namely uncontrolled dislocation of coils from
the aneurysm sack to the artery, the surgical intervention may
give a chance to level the negative sequelae [8]. For these
reasons, regardless of the increasing quality and rapid
improvement of endovascular techniques there are no progno-
ses for classical surgical methods to be displaced.
The growing experience of applying both methods has
allowed to elaborate certain preferences as to the choice of the
treatment. The localization of the lesion plays a particularly
signiﬁcant role. In neurosurgery, with regard to the differences
in the difﬁculty of accessing, a division into an anterior and
posterior part of the circle of Willis has been commonly
accepted. The superiority of embolization has been naturally
and indisputably acknowledged for the aneurysms of the
posterior part of the circle which are signiﬁcantly harder to
access surgically. Noticeable tendencies that differentiate the
results of treatment are also formed with regard to such
parameters as the size of the aneurysms, the age of the
patients, their initial condition and more speciﬁc localizations,
yet they contemporarily remain more as observations than
certainties [4,5,9–11]. On the contrary, in case of the aneurysms
located in the anterior part of the circle of Willis, there are no
premises indicating the predominance of either method.
Certainly, there are comparisons presenting better results
after embolization; nevertheless, their critical analysis and the
assessment of late results throw doubt on such unambiguous
conclusions. Alike is the case of ISAT – currently the biggest
and the most well-known prospective study which directly
compares the results of treating bleeding aneurysms with
clipping and endovascular embolization [12,13]. There are
some randomized trials concerning bleeding aneurysms,
however the number and quality of studies comparing the
results of treatment of unruptured aneurysms is insufﬁcient.
For these reasons, apart from the aneurysms occurring in the
posterior part of the circle, the choice between the endovas-
cular embolization and clipping as the optimal form of
treatment remains opened.
The aim of this research was to compare the early and late
results of treating intracranial aneurysms located in the anteriorpart of the circle of Willis with the use of two different methods:
clipping and endovascular embolization. An attempt has been
undertaken to answer the question whether the results of the
treatment with these methods vary and if they depend on the
presence or absence of bleeding from the aneurysm.
2. Materials and methods
The assessment embraced all 165 consecutive patients treated
for aneurysms located in the anterior part of the circle of Willis
in the years 2003–2008. In 24 cases more than one aneurysm
was treated in one patient. Twelve patients underwent more
than one procedure (from 2 to 4). Three patients were
excluded: two of them with non-bleeding aneurysm treated
with both endovascular and surgical methods and one person
with unfavourable results of simultaneous treatment of the
ruptured basilar artery aneurysm.
The decision about the type of therapy was taken by the
neurosurgeon on the basis of the evaluation of the condition of
the patients, the results of the imaging, the opinion of the
interventional neuro-radiologist and the choice of the patients
themselves, if their condition allowed for a conscious consent.
In some cases the choice of the method was limited by its
availability. The technical limitations always concerned coiling,
never clipping.
The study evaluated the outcome of patients instead of
particular aneurysms. For the assessment the Glasgow Outcome
Scale (GOS) [14] and the modiﬁed Rankin scale (mRs) [15] were
applied. For estimating the quality of life the quality of life
questionnaire EORTC QLQ-C30, version 3.0 [16,17] was employed
as well as a self-created survey which included questions about
the change in the overall health condition after treatment,
coming back to work and other possible changes in the social
functioning. The condition on the day before the intervention or
the day of the intervention was assumed to be the initial
condition whereas the treatment results were estimated for two
periods: the condition on the last day of hospitalization and the
condition after at least one year from the procedure. The grades 4
and 5 on the GOS scale and 0, 1 and 2 on the mRs scale were
assumed as a ‘‘good’’ result. The ‘‘death’’ result corresponded
with the grade 1 on the GOS scale and 6 on the mRs scale. Due to
the expected signiﬁcant majority of good results in the treatment
of non-bleeding aneurysms another group has been distin-
guished of ‘‘very good’’ results embracing the grade of 5 on the
GOS and 0 and 1 on the mRs scale. For the assessment of the early
complications all signiﬁcant, undesirable events were acknowl-
edged, not only those which could be directly related with the
given procedure. The complications which were conceived as
signiﬁcant were those that did not abate before being discharged
and inﬂuenced the functioning of the patients.
The shortest time of observation was 19 months and the
longest 94 months. The middle time was 52.2 months (SD
 19.2), which is more than 4 years. The majority of the group
(69.8%; n = 113) were women. The age varied from 21 to 78
years, 51.9 years on average (SD  10.4, median = 52 years). The
examined group contained 86 patients with bleeding and 76
patients with non-bleeding aneurysms. Among 48 patients
coiling was performed and among 114 patients the aneurysms
were clipped.
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Fig. 1 – Distribution of patients in groups I–V of Hunt and Hess scale in patients with bleeding aneurysms (X – insufficient data
to determine the state).
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cases out of 162 i.e. 82.7% of the patients. Eight patients did not
ﬁll in or ﬁlled the questionnaires improperly; therefore, the
estimation of the quality of life was only possible among 103
people altogether.
For the purposes of the analysis the group of 162 patients
was subdivided into four groups:
A. People with bleeding aneurysms treated with endovascular
embolization (n = 17).
B. People with non-bleeding aneurysms treated with endo-
vascular embolization (n = 31).
C. People with bleeding aneurysms treated with clipping
(n = 69).
D. People with non-bleeding aneurysms treated with clipping
(n = 45).
The late results of the treatment were assessed among the
following number of patients in each group: A = 16, B = 27,
C = 55, D = 36 (134 altogether).Table 1 – Comparison of outcome for all coiled and clipped an
All aneurysms 
Early outcome
Death 
Good outcome GOS (4,5) 
Very good outcome GOS (5) 
Signiﬁcant complications 
Late outcome
Death 
Good outcome GOS (4,5) 
Very good outcome GOS (5) 
Good outcome mRs (0,1,2) 
Very good outcome mRs (0,1) 
Self-assessment – without comp
Deterioration of social functioni
Back to work 
EORTC QLQ-C30 mean values Functional scale 
Symptom scale 
Global health status Before comparing the outcome the homogeneity of the
above-mentioned groups of patients was checked according to
their gender and age and for the bleeding aneurysms
additionally according to the initial condition established
with the Hunt and Hess scale.
The signiﬁcance level of p = 0.05 was acknowledged to be
relevant for the veriﬁcation of the presumed hypotheses.
3. Results
3.1. The comparison of the homogeneity of the groups
In all sets of groups of patients divided according to the
method of the treatment (coiling versus clipping) no signiﬁ-
cant differences were observed with relation to the gender and
age. In the group of patients with bleeding aneurysms (A + C) a
greater percentage of women was stated than in the group
with non-bleeding (B + D): 78.9–61.6%, p = 0.02.eurysms.
Coiling Clippling p
n (%) n (%)
3 (6.3%) 10 (8.8%) 0.62
33 (71.7%) 78 (69.0%) 0.73
18 (39.1%) 48 (42.5%) 0.70
16 (33.3%) 27 (23.7%) 0.21
7 (16.3%) 16 (17.6%) 0.85
34 (79.1%) 69 (75.8%) 0.67
22 (51.2%) 45 (49.5%) 0.85
34 (79.1%) 66 (72.5%) 0.41
22 (51.2%) 48 (52.7%) 0.86
romising 25 (78.1%) 55 (77.5%) 0.94
ng 11 (35.5%) 27 (38.6%) 0.77
13 (54.2%) 20 (46.5%) 0.55
70.3 67.0 0.78
25.5 25.6 0.62
58.3 57.2 0.81
Table 2 – Comparison of outcome for bleeding aneurysms.
Bleeding aneurysms Coiling Clippling p
n (%) n (%)
Early outcome
Death 1 (5.9%) 9 (13.0%) 0.39
Good outcome GOS (4,5) 7 (43.8%) 35 (51.5%) 0.58
Very good outcome GOS (5)
Signiﬁcant complications 7 (41.2%) 23 (33.3%) 0.55
Late outcome
Death 5 (31.3%) 15 (27.3%) 0.76
Good outcome GOS (4,5) 11 (68.8%) 34 (61.8%) 0.61
Very good outcome GOS (5)
Good outcome mRs (0,1,2) 11 (68.8%) 31 (56.4%) 0.37
Very good outcome mRs (0,1)
Self-assessment – without compromising 6 (75.0%) 24 (64.9%) 0.57
Deterioration of social functioning 2 (28.6%) 22 (59.5%) 0.12
Back to work 3 (42.9%) 9 (37.5%) 0.80
EORTC QLQ-C30 mean values Functional scale 76.8 61.6 0.22
Symptom scale 15.5 23.9 0.02
Global health status 65.8 53.8 0.12
Results that differ signiﬁcantly are bolded.
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clipped bleeding aneurysms (Fig. 1) among particular groups (I–V)
on the Hunt and Hess scale with the use of a test for two fractions
no important difference was discovered. However, comparing the
array of the patients between coiling and clipping in some groups,
especially II and IV, considerable differences may be observed
reaching more than double. In this respect it ought to be assumed
that the fact of not discovering signiﬁcant differences is the effect
of a too little number of patients in the examined groups rather
than an actual lack of difference.
3.2. The comparison of the results of the treatment
After summarizing the results it has been stated that the
outcomes for non-bleeding aneurysms are far better than ofTable 3 – Comparison of outcome for non-bleeding aneurysms
Non-bleeding aneurysms 
Early outcome
Death 
Good outcome GOS (4,5) 
Very good outcome GOS (5) 
Signiﬁcant complications 
Late outcome
Death 
Good outcome GOS (4,5) 
Very good outcome GOS (5) 
Good outcome mRs (0,1,2) 
Very good outcome mRs (0,1) 
Self-assessment – without compr
Deterioration of social functionin
Back to work 
EORTC QLQ-C30 mean values Functional scale 
Symptom scale 
Global health status 
Results that differ signiﬁcantly are bolded.those with bleeding ones (B + D/A + C). Such results had been
obvious and therefore the presentation of the analysis in these
groups has been omitted.
For all the examined parameters no signiﬁcant differences
were observed between the total results of the patients with
embolized and clipped aneurysms (A + B/C + D) both in the
early and long-term period (Table 1).
As far as the late assessment of the patients with bleeding
aneurysms, better results of the treatment were revealed
among the people who had undergone embolization; still, the
statistical signiﬁcance was only acknowledged with regard to
the medium score of the symptomatic scale of the quality of
life EORTC QLQ-C30 questionnaire (Table 2).
In the assessment of the patients with non-bleeding
aneurysms better results of the treatment were noticed among.
Coiling Clippling p
n (%) n (%)
2 (6.5%) 1 (2.2%) 0.34
26 (86.7%) 43 (95.6%) 0.17
16 (53.3%) 35 (77.8%) <0.03
9 (29.0%) 4 (8.9%) 0.02
2 (7.4%) 1 (2.8%) 0.40
23 (85.2%) 35 (97.2%) 0.07
17 (63.0%) 27 (75.0%) 0.30
23 (85.2%) 35 (97.2%) 0.07
17 (63.0%) 27 (75.0%) 0.30
omising 19 (79.2%) 31 (91.2%) 0.20
g 9 (37.5%) 5 (15.2%) 0.053
10 (58.8%) 11 (57.9%) 0.95
68.1 72.4 0.22
28.9 27.3 0.95
55.8 60.9 0.40
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cance was only obtained with regard to the early results: more
‘‘very good’’ scores on the GOS scale at the point of being
discharged and less complications during the hospitalization.
With regard to the late results, however, the differences in neither
of the parameters obtained statistical signiﬁcance though being
close in some cases: more ‘‘good’’ scores on the GOS and mRs
scales in the late assessment ( p = 0.07) and less frequent cases of
a relapse in the social functioning ( p = 0.053) (Table 3).
4. Discussion
4.1. The controversies in the epidemiology of the
intracranial aneurysms
Signiﬁcant differences start at the stage of determining the
prevalence of intracranial aneurysms. Often proclaimed the
value of 5% should be treated with caution because the spread of
the results calculated on the basis of autopsy or radiologic
examinations is high and ranges from 0.2 to 9%. Most published
results of large studies are within 0.4–6% [9,18–22]. Only the
epidemiologic data concerning the subarachnoid haemorrhage
(SAH) may be regarded as coherent and well documented. Fear of
recurrent bleeding, which is burdened with a high, more than
70% mortality warrant preventive treatment [23,24]. On the other
hand, before deciding on undertaking the treatment of the non-
ruptured aneurysms, additional role is played by the knowledge
of the risk of the initial bleeding which has not yet been precisely
determined. The authors of the most extensive studies have
calculated it at the level of 1–2% annually [21,22,25–27]. These
data were shaken by the results of a multicenter study ISUIA,
the ﬁrst retrospective part was published in 1998 [28], and the
extension including prospective part in 2003 [29]. The results of
the research conﬁrmed earlier observations that the risk of
aneurysm rupture increases with its size; however, the risk
concerning the small aneurysms, especially the anterior
circulation, proved unexpectedly low. In the ﬁrst part it was
established that the annual risk of the rupture of silent
aneurysms diameter up to 10 mm equals 0.05%. In the second
part, cumulated, 5-year-long risk of the rupture of the anterior
circle of Willis aneurysms was calculated at the value of 0% for
the aneurysms smaller than 7 mm without ﬁnding a single case
of bleeding in this group, 2.6% for 7–12 mm, 14.5% for 13–24 mm
and 40% for 25 mm and bigger. The aneurysms of the posterior
part of the circle equalled respectively 2.5%, 14.5%, 18.4% and
50%. Such unexpected results were even more surprising due to
the fact that in clinical practice bleeding from the small
aneurysms is not rare. The ISUIA research was currently the
biggest and the most systemized attempt to assess the natural
course of the intracranial aneurysms and the risk of treatment
carried in accordance with the accepted standards of the
Evidence-based Medicine. For this reason the announced results
had wide repercussions among neurosurgeons and in many
medical centres inﬂuenced the approach towards small aneur-
ysms. Ofﬁcial recommendations by authorities appeared in i.a.
‘‘Stroke’’ in 2000 [6] suggesting that the risk of treating exceeds
the risk natural course of the disease and therefore small
aneurysms should not be treated at all. After a time, there is a lot
of controversy about the ISUIA study. The main doubt becamethe dissonance between the risk of rupture of the small
aneurysms and the observable in practice number of bleedings
from small aneurysms which is impossible if the frequency of
aneurysms do not exceed a few percent. On the basis of the
American population, Winn et al. outnumbered that if such a low
risk of rupture of the small aneurysms was accepted the
frequency of their occurrence would need to reach not few but
tens of percent to cause the approximately 30,000 cases of
subarachnoid haemorrhages in the United States annually with
the assumption that half of them derived from small aneurysms.
[30] Down to the fact that the epidemiologic data: incidence of
bleeding and the prevalence of the aneurysms have ground basis,
such a low probability of rupture of small aneurysms that was
claimed by the ISUIA could be regarded as unreliable. It was
noticed that the inclusion of patients had been a result of a careful
selection anddid not reﬂect theproﬁle of patients with aneurysms
of the general population [31,32]. Only patients who had not
undergone treatment after neurosurgical assessment were
qualiﬁed for the observation. Undoubtedly observed aneurysms
were considered to be safer. Most probably this was the reason
why a smaller number of patients with aneurysms of the anterior
cerebral artery and the anterior communicating artery complex
(10%) were entered into the study than in general population
(>30%). During the observation period, which lasted an average of
4.1 years 51 cases of conﬁrmed aneurysm rupture were noticed.
534 out of the initial group of 1692 patients were excluded and
submitted to treatment. Among them were, probably, patients in
whom an increase of the risk of rupture was suspected due to e.g.
enlargement of the aneurysm. Another 193 people were excluded
due to their death. In 52 cases among them the cause of death was
an intracranial bleeding and heart attack in only 14. The cause of
death of 11 patients was not known. Therefore, among the overall
number of 63 deceased as a result of intracranial bleeding and
unknown causes in the major part the cause of death could have
been ruptured aneurysms. In this respect the conclusions of the
ISUIA concerning small aneurysms seem useless in clinical
practice except the conﬁrmation that intuitive assessment of
neurosurgeons in choosing ‘‘safer’’ aneurysms is effective.
In 2004 Mocco et al. published an analysis of a number of
research in the ﬁeld of the natural course of unruptured
aneurysms including ISUIA. By this analysis, the annual risk of
rupture of 7–10 mm aneurysm is approximately 1% and
increases with the increasing size [33].
Inasmuch as the morbidity rate from subarachnoid
haemorrhage increases with age, an increase in the frequency
of SAH should be expected due to the ageing of the population.
However, the statistical reports do not conﬁrm such ﬁndings.
In the paper published by de Rooij et al. [34] it has been stated
that between 1950 and 2005 the morbidity from SAH decreased
by 0.6%. The data could conﬁrm the effectiveness of the
prophylaxis: better control of the arterial hypertension and a
reduction in the percentage of smokers, and perhaps some-
what conﬁrms the validity and effectiveness of preventive
treatment of silent aneurysms.
4.2. The results of the treatment in other studies and their
faults
In the majority of published studies and meta-analyzes the
risk of death and morbidity after clipping rated for a few to over
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claimed the postsurgical death rate at the level of 1% whereas
the neurological relapse at 4.1%. Raaymakers et al. [36] in 1998
calculated respectively 2.6% and 10.9%. In the analyses better
results have been observed in more recent works. The
administrative data from the discharge forms in New York
and California [6], however, suggest worse results of the
treatment: the death rate 2.5–3% and complications rate 21.3–
22.4%. In the prospective part of ISUIA the total death rate and
morbidity after 1 year was estimated at the level of 15% [29].
Against this background the results of endovascular treatment
seem encouraging especially those from recent years. In 2008
two prospective multicenter research were broadcasted that
concerned endovascular treating of brain aneurysms. The
HELPS [37] embraced people with ruptured and unruptured
aneurysms noticing only 2 deceases among 218 cases of
unruptured aneurysms (0.9%). In the ATENA research 739
aneurysms were treated in 649 patients [38]. The early
neurological complications were stated amidst 5.4% of the
patients.
So far ISAT remains the largest, most well-known,
international, randomized trial directly comparing the results
of the treatment of bleeding aneurysms by clipping and
endovascular embolization remains ISAT [12,13]. A bad result
was death and dependency of patients included in mRs scale
of 3–6 points. After one year of follow-up poor outcome was
observed in 30.6% of patients after clipping and in 23.7% of
patients after coiling. Due to a signiﬁcant difference in 2002 the
recruitment was ceased at the number of 2143 patients but
only 1594 of them completed a one-year observation period
and the fate of the remaining 549 is unknown. The candidates
were selected from among 9559 patients with SAH, which
represents about 22% of the total, and only 17% of those who
completed the study. After 5 years the results of treatment
equalized. Among survivors 83% were independent (0–2 points
on the mRs) in the coiling group, and 82% in the clipping group.
A statistically signiﬁcant difference was only given in the
deaths: 112 (11%) after embolization and 144 (14%) after
clipping. However, as Bakker et al. [39] indicated, for the
calculation of the real results, the deceases from the period
between the randomization and surgery should have been
omitted. In this period in 17 patients awaiting coiling recurrent
bleeding was noticed and 7 of them died, whereas among
patients who awaited clipping, 28 cases of recurrent bleeding
were noticed and 19 of them died. The difference may have
resulted from a longer waiting period in case of clipping (1.7
days) than coiling (1.1 days). After subtracting the number of
deaths before the treatment the difference between coiling
and clipping reduced without reaching statistical signiﬁcance.
In another major trial BRAT carried in a single medical
centre and embracing 500 patients with SAH with the
assumptions similar to ISAT, analogous results were pre-
sented. Ultimately 403 patients were assessed: death or
dependence was stated among 33.7% of people after clipping
and among 23.2% after embolization. What is noticeable in
this case is the fact that 75 patients who were initially
planned for endovascular treatment were eventually sub-
mitted for surgery mainly down to anatomical difﬁculties. By
contrast, only four patients planned for surgery were treated
endovascularily [7].The comparisons of outcome after treatment of unruptured
aneurysms remain less elaborated. In the II part of the ISUIA trial
published in 2003 [29] the rate of mortality and morbidity one
year after treatment was found to be 12.6% for clipping and 9.8%
for coiling. The possibility of a direct comparison of the results of
both groups is limited due to the initial difference between the
groups and unclear qualiﬁcation principles. In 1999 Johnston
et al. [40] published the results of the treatment of unruptured
aneurysms in university hospitals in the USA. 18.5% of patients
after clipping died or were discharged not to their homes and
that was only 10.6% of patients after embolization. Nevertheless
the groups were again incomparable.
4.3. The limitations of our research
The most important seems the scarce number of testees
(n = 162) which provides statistically weaker results after
subdividing. Moreover, the research embraces material from
a single centre and is strictly ground in the local realities shaped
by organizational limitations, the availability of the equipment,
the skills and the learning curve of the doctors performing the
surgeries. The endovascular embolization was carried out by
two neuroradiologists whereas the surgeries were performed by
several neurosurgeons wherein the majority of the clipped
aneurisms were supplied by a single, experienced surgeon.
The research was not randomized. Therefore, regardless of the
homogeneity tests of the groups, the individual choice of the
method of treatment could disturb the balance in relationwith the
unknown prognostic factors. It has to be indicated that the choice
of method was often limited by its availability. The limitations
always concerned coiling, never clipping. They were related to a
temporal lack of staff or equipment for coiling. The embolizations
were conducted only in a planned mode. In emergencies beyond
typical working hours only neurosurgeons were available and in
such situations the aneurysms were usually clipped. We sought
as soon as possible to treat bleeding aneurysms hence emerged
much larger number of subgroup of clipped bleeding aneurysms
(n = 69) compared to coiled ones (n = 17).
No statistical signiﬁcance was stated upon the comparison
of the homogeneity of the groups; however, the distribution of
the embolized and clipped bleeding aneurysms in certain
groups along Hunt–Hess scale was not equal. Patients in worse
condition were more often qualiﬁed for coiling. In the context
of the obtained results such an array reinforces the indicated
difference in favour of the embolization among patients with
bleeding aneurysms.
In two patients with non-bleeding aneurysms who were
excluded, coiling applied was yet ineffective and complicated.
Eventually they underwent surgical treatment. In these cases
the neurological relapse and decrease of the quality of life
burden embolization. Therefore, if they were included in the
embolized group the observed differences in the results would
increase in favour of clipping.
5. Conclusions
1. The early and long-term results of treating both bleeding
and non-bleeding aneurysms of the anterior part of the
circle of Willis are no different.
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can be obtained by applying endovascular embolization.
3. Among patients with non-bleeding aneurysms better
results may be obtained by applying clipping.
4. The results of the research suggest that with the lack of
other circumstances as to the choice of treatment in case of
the bleeding aneurysms the priority should be given to the
endovascular treatment. On the other hand, in case of non-
bleeding aneurysms it is clipping that should be considered
ﬁrst.
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